Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians-Reference-Cited by-同舟云学术

Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metformin in Jordanians

Published:2017-01-01 Issue:3 Volume:32 Page:
ISSN:2363-8915
Container-title:Drug Metabolism and Personalized Therapy
language:
Short-container-title:

Author:

Hakooz Nancy,Jarrar Yazun Bashir,Zihlif Malik,Imraish Amer,Hamed Saja,Arafat Tawfiq

Abstract

AbstractBackground:Human response to the antidiabetic metformin is influenced by some factors, such as genetic variants in thePatients and methods:TheResults:Results showed that volunteers withConclusions:The

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Link

https://www.degruyter.com/document/doi/10.1515/dmpt-2017-0019/pdf

Reference60 articles.

1. HPLC method for estimation of metformin hydrochloride in formulated microspheres and tablet dosage form;Indian J Pharm Sci,2009

2. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics;Clin Pharmacol Ther,2008

3. Should we use N-acetyltransferase type 2 genotyping to personalize isoniazid doses?;Antimicrob Agents Chemother,2005

4. Pharmacogenetics and personalized treatment of type 2 diabetes;Biochem Med (Zagreb),2013

5. The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin;Clin Pharmacol Ther,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of OCT3 and MATE2 Genetic Polymorphisms in Poor Response to Metformin in Type 2 Diabetes Mellitus;Endocrinology, Diabetes & Metabolism;2024-07-31

2. Diet control and BMI impact on Metformin response in type 2 Diabetes mellitus patients;Wiadomości Lekarskie;2024

3. Influence of different factors (duration of disease, gender, education, patients’ history, job and age) in metformin response in type 2 diabetes mellitus patient;Wiadomości Lekarskie;2024

4. Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review;Current Diabetes Reviews;2023-10-05

5. Clinical Significance of NAT2 Genetic Variations in Type II Diabetes Mellitus and Lipid Regulation;Pharmacogenomics and Personalized Medicine;2023-09